Morphological features of the skin microcirculatory bed in patients with psoriasis and essential hypertension.

Authors

  • G. I. Makurina Zaporizhzhia State Medical University, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2016.1.38-48

Keywords:

psoriasis, hypertension, skin, microcirculatory bed, morphology.

Abstract

Background. Many questions about pathomorphogenesis of damage of the skin microcirculatory bed in patients with psoriasis and hypertension on the background of the skin age changes require clarification and further advance. Objective. The aim of research is to determine the damages of the skin microcirculatory bed in psoriasis patients, depending on the presence or absence of hypertension. Methods. In 60 patients with active psoriasis with and without hypertension skin biopsies were studied using light-optical microscopy. In quantitative morphological study the maximum and minimum overall length of basal, spinous and granular layers of the epidermis were explored, numerical density of nuclei and mitotic index of keratinocytes were calculated. Results. It was found that the morphological basis of damages of the skin microcirculatory bed in patients with psoriasis and hypertension is a complex of general vascular changes: hyperproliferation of microvascular wall cells (endothelial cells, pericytes, smooth myocytes) with the development of hyalinosis and elastofibrosis of arterioles, disseminated abuse of angioarchitectonics of arterioles and intrapapillary hemocapillaries. It triggers a cascade of typical pathomorphological changes of significantly higher intensity than the skin lesions in psoriasis patients without hypertension. Conclusion. Comorbid morphogenesis causes dermal damage in patients with psoriasis and hypertension: significant interstitial edema of papillary layer; perifocal leukocyte infiltration, exudation, extravasations, plasmorrhage consisting of dermal papillae; lymphostasis and local extension of lymphatic drainage; erythrocyte sludging, erythrodiapedesis, hemorrhage; strengthening of endothelial dysfunction with activation of vascular-platelet hemostasis.

References

  1. Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H, Chen C, Riblett M, John-ston A, Gudjonsson JE, Helfrich Y, Kang S, Fisher GJ, Voorhees JJ. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24. Br J Dermatol. 2012 Jul;167(1):92-102. doi: 10.1111/j.1365-2133.2012.10961.x.
  2. Quan T, Johnston A, Gudjonsson JE, Fisher GJ. CYR61/CCN1: a novel mediator of epidermal hyperplasia and inflammation in psoriasis? J Invest Dermatol. 2015 Nov;135(11):2562-4. doi: 10.1038/jid.2015.300.
  3. Singh TP, Schön MP, Wallbrecht K, Gruber-Wackernagel A, Wang XJ, Wolf P. Involvement of IL-9 in Th17-associated inflammation and angio-genesis of psoriasis. PLoS One. 2013;8(1):e51752. doi: 10.1371/journal.pone.0051752.
  4. Johnston A, Guzman AM, Swindell WR, Wang F, Kang S, Gudjonsson JE. Early tissue re-sponses in psoriasis to the antitumour necrosis fac-tor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling. Br J Dermatol. 2014 Jul;171(1):97-107. doi: 10.1111/bjd.12937.
  5. Stepanenko RL, Gichka SG. [To the problem of morphogenesis of skin rash elements in psoriasis]. Ukrainian journal of dermatology, venereology, cosmetology. 2014;(3):19-23. Ukrainian.
  6. Căruntu C, Boda D, Căruntu A, Rotaru M, Baderca F, Zurac S. In vivo imaging techniques for psoriatic lesions. Rom J Morphol Embryol. 2014;55(3 Suppl):1191-6.
  7. Baliwag J, Barnes DH, Johnston A. Cyto-kines in psoriasis. Cytokine. 2015 Jun;73(2):342-50. doi: 10.1016/j.cyto.2014.12.014.
  8. Hugh J, Van Voorhees AS, Nijhawan RI, Bagel J, Lebwohl M, Blauvelt A, Hsu S, Weinberg JM. From the Medical Board of the National Psoria-sis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014 Jan;70(1):168-77. doi: 10.1016/j.jaad.2013.09.020.
  9. Wu S, Han J, Li WQ, Qureshi AA. Hyper-tension, antihypertensive medication use, and risk of psoriasis. JAMA Dermatol. 2014 Sep;150(9):957-63. doi: 10.1001/jamadermatol.2013.9957.
  10. Tverdokhlib IV, Makarchuk OI. [Morpho-logical characteristics of temporal area skin in pa-tients with an additional pathology on age aspect]. Morphologia. 2015;9(3):83-8. Ukrainian.
  11. Sarkisov DS, Perov YuL, editors. [Micro-scopic technique: a guide]. Moscow: Meditsina; 1996. 544 p. Russian.
  12. Collins TJ. ImageJ for microscopy. Biotechniques. 2007 Jul;43(1 Suppl):25-30.
  13. Avtandilov GG. [Medical morphometry]. Moscow: Meditsina; 1990. 384 p. Russian.
  14. Méndez-Vilas A, Rigoglio NN, Mendes Silva MV, Guzman AM, Swindell WR. Current mi-croscopy contributions to advances in science and technology. Badajoz: Formatex; 2012. 1523 p.
  15. Lakin GF. [Biometrics]. 4th ed rev and enl. Moscow: Vysshaya shkola; 1990. 352 p. Russian.

How to Cite

Makurina, G. I. (2016). Morphological features of the skin microcirculatory bed in patients with psoriasis and essential hypertension. Морфологія / Morphologia / Morfologìâ, 10(1), 38–48. https://doi.org/10.26641/1997-9665.2016.1.38-48

Issue

Section

Статті